Breaking News Instant updates and real-time market news.

MDSO

Medidata

$75.48

-12.94 (-14.63%)

05:42
07/25/18
07/25
05:42
07/25/18
05:42

Medidata selloff yesterday a buying opportunity, says Piper Jaffray

Piper Jaffray analyst Sean Wieland recommends using the post-earnings selloff yesterday in shares of Medidata Solutions as a buying opportunity. The analyst views the pullback as overdone and reiterates an Overweight rating on the stock with a slightly reduced price target of $96. Contract timing and the addition of Shyft will accelerate backlog and subscription revenue in the second half of 2018 and continue into 2019, Wieland tells investors in a research note.

MDSO Medidata
$75.48

-12.94 (-14.63%)

07/17/18
RBCM
07/17/18
UPGRADE
Target $100
RBCM
Outperform
Medidata upgraded to Outperform at RBC Capital on positive drug funding backdrop
As reported earlier, RBC Capital analyst George Hill upgraded Medidata to Outperform from Sector Perform and raised his price target to $100 from $83. The analyst says the company "well-positioned" to benefit from a favorable drug research funding environment and fund inflows as investors look for opportunities in the sector that are not affected by Amazon's (AMZN) expected entry into the drug distribution business or the "precarious generic drug pricing environment". Hill further states that Medidata's "viable footprint" in the top-25 commercial trial sponsors and its "strong demand for increasingly sophisticated IT solutions in the trial process" should drive cross-sales opportunities.
07/24/18
JPMS
07/24/18
DOWNGRADE
JPMS
Neutral
Medidata downgraded to Neutral from Overweight at JPMorgan
07/24/18
JPMS
07/24/18
DOWNGRADE
JPMS
Neutral
JPMorgan downgrades Medidata to Neutral on subscription sales miss
JPMorgan analyst Sterling Auty downgraded Medidata Solutions to Neutral from Overweight with a 2019 price target of $87. The stock in afternoon trading is down 12%, or $10.47, to $77.80 following this morning's Q2 results. The inconsistency in subscription revenue growth "popped back up in the quarter," Auty tells investors in a research note. The analyst sees a road back to $87 per share, but says the 10% upside for current price levels justifies a Neutral rating. He attributes the earnings beat in Q2 to "below-the-line items" and notes that subscription revenue missed expectations.
07/24/18
KEYB
07/24/18
NO CHANGE
Target $88
KEYB
Overweight
Medidata backlog growth a better forward indicator than fee growth, says KeyBanc
KeyBanc analyst Donald Hooker reiterated his Overweight rating on Medidata despite the company reporting weaker than expected Q2 subscription fee growth, which he attributes to contract timing in newer product categories. Hooker, who points to the Q2 backlog growth of about 18% as a better leading indicator of forward growth, keeps an $88 price target on Medidata shares.

TODAY'S FREE FLY STORIES

WORK

Slack Technologies

$34.43

-0.35 (-1.01%)

, MSFT

Microsoft

$137.08

-1.86 (-1.34%)

06:19
07/17/19
07/17
06:19
07/17/19
06:19
Initiation
Slack Technologies, Microsoft, Alphabet, Alphabet Class A initiated  »

Slack Technologies…

WORK

Slack Technologies

$34.43

-0.35 (-1.01%)

MSFT

Microsoft

$137.08

-1.86 (-1.34%)

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 06

    Aug

  • 08

    Aug

  • 27

    Oct

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

, GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

06:18
07/17/19
07/17
06:18
07/17/19
06:18
Periodicals
Google terminating 'Project Dragonfly' censored search engine for China, BI says »

Google is killing the…

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

ADBE

Adobe

$305.76

-2.95 (-0.96%)

06:18
07/17/19
07/17
06:18
07/17/19
06:18
Recommendations
Adobe analyst commentary  »

UBS believes Adobe can…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$40.57

-1.04 (-2.50%)

06:16
07/17/19
07/17
06:16
07/17/19
06:16
Upgrade
Progress Software rating change  »

Progress Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

, GOOG

Alphabet

$1,152.97

2.58 (0.22%)

06:15
07/17/19
07/17
06:15
07/17/19
06:15
Periodicals
Palantir co-founder Joe Lonsdale calls Google 'unpatriotic,' CNBC reports »

The co-founder of data…

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

OMP

Oasis Midstream Partners

$21.78

(0.00%)

06:15
07/17/19
07/17
06:15
07/17/19
06:15
Initiation
Oasis Midstream Partners initiated  »

Oasis Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

06:14
07/17/19
07/17
06:14
07/17/19
06:14
Initiation
Tallgrass Energy initiated  »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NGL

NGL Energy Partners

$15.30

0.11 (0.72%)

06:13
07/17/19
07/17
06:13
07/17/19
06:13
Initiation
NGL Energy Partners initiated  »

NGL Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$32.45

-0.3 (-0.92%)

06:13
07/17/19
07/17
06:13
07/17/19
06:13
Initiation
Noble Midstream initiated  »

Noble Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

IMRN

Immuron

$4.27

1.43 (50.35%)

06:11
07/17/19
07/17
06:11
07/17/19
06:11
Syndicate
Immuron 339.1K share Spot Secondary priced at $4.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PAA

Plains All American

$24.57

-0.04 (-0.16%)

06:10
07/17/19
07/17
06:10
07/17/19
06:10
Initiation
Plains All American initiated  »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ET

Energy Transfer LP

$14.94

0.03 (0.20%)

06:10
07/17/19
07/17
06:10
07/17/19
06:10
Initiation
Energy Transfer LP initiated  »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$144.33

-0.72 (-0.50%)

06:09
07/17/19
07/17
06:09
07/17/19
06:09
Periodicals
Disney collects data on Disneyland guests via 'MagicBands,' Bloomberg reports »

Disney monitors usage of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

EPD

Enterprise Products

$30.32

0.005 (0.02%)

06:08
07/17/19
07/17
06:08
07/17/19
06:08
Initiation
Enterprise Products initiated  »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 31

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

06:07
07/17/19
07/17
06:07
07/17/19
06:07
Downgrade
CSX rating change  »

CSX downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

MTSI

Macom

$15.55

0.01 (0.06%)

06:06
07/17/19
07/17
06:06
07/17/19
06:06
Upgrade
Macom rating change  »

Macom upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$203.87

-0.06 (-0.03%)

06:05
07/17/19
07/17
06:05
07/17/19
06:05
Periodicals
Swiss group FDPIC says hasn't heard from Facebook over Libra, CNBC reports »

David Marcus, the head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

ONDK

On Deck Capital

$3.99

0.06 (1.53%)

06:03
07/17/19
07/17
06:03
07/17/19
06:03
Hot Stocks
On Deck Capital, Upserve announce financing partnership »

OnDeck and Upserve, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 06

    Aug

  • 13

    Nov

SCS

Steelcase

$17.43

-0.21 (-1.19%)

06:03
07/17/19
07/17
06:03
07/17/19
06:03
Downgrade
Steelcase rating change  »

Steelcase downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$2,010.00

-11 (-0.54%)

06:02
07/17/19
07/17
06:02
07/17/19
06:02
Hot Stocks
EU opens investigation into potential anti-competitive conduct of Amazon »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 25

    Jul

PSO

Pearson

$11.01

0.24 (2.23%)

06:00
07/17/19
07/17
06:00
07/17/19
06:00
Periodicals
Pearson plans to phase out print textbooks, BBC News reports »

Education publisher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$252.38

-1.03 (-0.41%)

05:53
07/17/19
07/17
05:53
07/17/19
05:53
Recommendations
Tesla Q2 results next catalyst in 'restoring bull thesis,' says Baird »

Baird analyst Ben Kallo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

SC

Santander Consumer

$25.55

-0.05 (-0.20%)

05:46
07/17/19
07/17
05:46
07/17/19
05:46
Downgrade
Santander Consumer rating change  »

Santander Consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 30

    Oct

MNK

Mallinckrodt

$8.19

-0.23 (-2.73%)

05:45
07/17/19
07/17
05:45
07/17/19
05:45
Recommendations
Mallinckrodt analyst commentary  »

Mallinckrodt halted trial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 09

    Sep

INTC

Intel

$49.17

-0.96 (-1.92%)

05:38
07/17/19
07/17
05:38
07/17/19
05:38
Recommendations
Intel analyst commentary  »

Nomura Instinet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.